Invention Grant
- Patent Title: Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)
-
Application No.: US16990929Application Date: 2020-08-11
-
Publication No.: US11891436B2Publication Date: 2024-02-06
- Inventor: Jörg Wischhusen , Markus Junker , Thomas Müller , Stefan Saremba
- Applicant: JULIUS-MAXIMILLIANS-UNIVERSITÄT WÜRZBURG
- Applicant Address: DE Würzburg
- Assignee: JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG
- Current Assignee: JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG
- Current Assignee Address: DE Würzburg
- Agency: Dechert LLP
- Agent Andrew T. Wilkins; Kayla L. Metzger
- Priority: EP 186185 2012.09.26
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/22 ; A61K45/06 ; A61K39/00
Abstract:
The present invention relates to novel monoclonal anti-human-GDF-15 antibodies, pharmaceutical compositions, kits, methods and uses and the cell lines capable of producing the monoclonal antibodies described herein. The present invention further relates to novel antibodies to human GDF-15 capable of inhibiting cancer growth.
Public/Granted literature
- US20210054060A1 MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15) Public/Granted day:2021-02-25
Information query
